NAFDAC announces end of Mojisola Adeyeye’s tenure as DG

National Agency for Food and Drug Administration and Control (NAFDAC) has announced the expiration of Mojisola Adeyeye as director-general of the agency.

The agency made the announcement in a public notice on Friday.

NAFDAC also said it has appointed Monica Eimunjeze as the acting director general of the agency.

The notice added that Eimunjeze’s appointment took effect on November 12, 2022.

“The Management of NAFDAC wishes to inform all stakeholders and the general public about the expiration of the tenure of office of her Director-General, Prof. Mojisola Christianah Adeyeye,” the notice reads.

“Consequently, the Federal Government has appointed the Agency’s Director of Drug Registration and Regulatory Affairs, Dr. Monica Hemben Eimunjeze as Acting Director-General with effect from 12th November, 2022.”

The announcement by NAFDAC comes days after an internal memo dated November 17 and seen by TheCable had announced Eimunjeze as acting director-general.

Adeyeye was appointed the DG of NAFDAC on November 3, 2017 for aa five-year term.

Exit mobile version